GlassScriptPhysician profile
Magdalena E Swierczewski
NPI 1811194954
$1,187.03
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $385 · 2022: $23.85.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $270.10 | 2019-2022 | |
| Merz North America, INC. | $168.02 | 2019 | |
| Amgen INC. | $124.57 | 2019-2020 | |
| Lilly USA, LLC | $122.07 | 2019-2020 | |
| Novo Nordisk INC | $114.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $86.95 | 2019-2020 | |
| Amarin Pharma, INC. | $67.88 | 2019-2020 | |
| Eisai INC. | $59.61 | 2019-2020 | |
| Astellas Pharma US INC | $29.66 | 2019-2020 | |
| Abbvie INC. | $23.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.71 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.33 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $21.19 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.93 | 2020 | |
| Merck Sharp & Dohme LLC | $16.78 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magdalena Swierczewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.